Literature DB >> 12054146

A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer.

P Edmonds1, S Karlsen, S Khan, J Addington-Hall.   

Abstract

This paper reports on data from the Regional Study of Care for the Dying, conducted in 1990, and compares symptoms, care and service utilization for patients with chronic lung diseases (CLD) and lung cancer (LC) in the final 12 months of life. Post-bereavement structured interviews were conducted with informal carers of 449 LC patients and 87 CLD patients. The LC patients were significantly younger than those with CLD (P = 0.001) and these respondents were more likely to have been a spouse (P = 0.034). No differences were found in the mean number of symptoms reported by the two groups in the final year or week of life, although the CLD patients were more likely to have experienced these symptoms for longer. Significantly more patients with CLD than LC experienced breathlessness in the final year (94% CLD vs 78% LC, P < 0.001) and final week (91% CLD vs 69% LC, P < 0.001) of life. Significantly more LC patients were reported to have experienced anorexia (76% LC vs 67% CLD, P = 0.06) and constipation (59% LC vs 44% CLD, p = 0.01) in the final year of life. There were no differences in general practitioner use, but LC patients were reported to have received more help from district nurses (52% LC vs 39% CLD, P = 0.025) and from a palliative care nurse (29% LC vs 0% CLD, P < 0.001). More CLD patients were reported to have received help from social services (29% CLD vs 18% LC, P = 0.037). LC patients were reported to be more likely to have known they might die (76% LC vs 62% CLD, P = 0.003) and to have been told this by a hospital doctor (30% LC vs 8% CLD, P = 0.001). Among those that knew, LC patients were told earlier prior to death than CLD patients. This study suggests that patients with CLD at the end of life have physical and psychosocial needs at least as severe as patients with lung cancer.

Entities:  

Mesh:

Year:  2001        PMID: 12054146     DOI: 10.1191/026921601678320278

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  73 in total

1.  [Palliative medicine and advanced incurable illness].

Authors:  J Gaertner; St Simon; R Voltz
Journal:  Internist (Berl)       Date:  2011-01       Impact factor: 0.743

2.  The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND.

Authors:  Marjolein H Gysels; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2011-10-17       Impact factor: 3.234

Review 3.  Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Authors:  Darcy D Marciniuk; Donna Goodridge; Paul Hernandez; Graeme Rocker; Meyer Balter; Pat Bailey; Gord Ford; Jean Bourbeau; Denis E O'Donnell; Francois Maltais; Richard A Mularski; Andrew J Cave; Irvin Mayers; Vicki Kennedy; Thomas K Oliver; Candice Brown
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

4.  Palliative care in primary care: a study to determine whether patients and professionals agree on symptoms.

Authors:  Gail Ewing; Margaret Rogers; Stephen Barclay; Janet McCabe; Anna Martin; Malcolm Campbell; Chris Todd
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

5.  End-of-life care for patients with COPD in the community setting.

Authors:  David M G Halpin; Clare J Seamark; David A Seamark
Journal:  Br J Gen Pract       Date:  2008-06       Impact factor: 5.386

6.  Acceptability and preferences of six different routes of drug application for acute breathlessness: a comparison study between the United Kingdom and Germany.

Authors:  Steffen T Simon; Anna Maria Niemand; Hamid Benalia; Raymond Voltz; Irene J Higginson; Claudia Bausewein
Journal:  J Palliat Med       Date:  2012-10-24       Impact factor: 2.947

Review 7.  Palliative care in chronic obstructive pulmonary disease: a review for clinicians.

Authors:  David A Seamark; Clare J Seamark; David M G Halpin
Journal:  J R Soc Med       Date:  2007-05       Impact factor: 5.344

Review 8.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

9.  Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis.

Authors:  Donna Goodridge; Josh Lawson; Graeme Rocker; Darcy Marciniuk; Donna Rennie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-05-06

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.